Smartlab Europe

News

Online Medicine in India: Where Ganaton Total Fits in Modern Digestive Care

The demand for online medicine delivery in India has grown rapidly as patients seek convenience without compromising on authenticity. With chronic digestive disorders on the rise, many physicians prescribe combination therapies such as Ganaton Total to manage complex gastrointestinal...

How Advanced Imaging and Digital Diagnostics Are Improving Patient Outcomes

Advancements in medical imaging and digital diagnostic technologies are reshaping how healthcare professionals detect, monitor, and treat a wide range of conditions. Over the past two decades, innovations such as high-resolution digital imaging, artificial intelligence-assisted analysis, and 3D visualization have...

A Guide to Exploring the Right Cancer Medication

Research and development efforts for making more effective cancer drugs are still ongoing. It might still take decades to come up with a drug that can help prevent and treat the condition altogether. For now, millions of cancer patients are...

Neuland Laboratories Expands Peptide Manufacturing Capacity

Neuland Laboratories is preparing to launch a new commercial peptide manufacturing facility at its 17-acre Bonthapally manufacturing campus, with the first phase expected to become operational in the summer of this year. The project forms part of a broader...

How to Find More Affordable Cancer Medication

Cancer treatment could set back patients by up to $20,000 per year, with the entire treatment duration possibly reaching more than a million dollars. Many who suffer from the condition are not only experiencing the physical and emotional pain...

The Hidden Risks of Combining Alcohol and Decongestants

We have all been there: a nagging head cold or sinus pressure hits right before a weekend plan or social gathering. It is incredibly tempting to take a Sudafed to clear your head and go out anyway, assuming a...

US FDA Approves Leucovorin for Rare Autism-Like Disorder

The U.S. Food and Drug Administration on Tuesday authorized the use of leucovorin, a long-established generic medicine, for the treatment of a rare genetic disorder associated with autism-like symptoms. The decision does not extend to children diagnosed with autism...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »